Mette Gyldenløve

Mette Gyldenløve

Clinical Associate Professor

Member of:

  • Dermatovenerology


Publication year:
  1. 2024
  2. Accepted/In press

    Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis – results from a randomized controlled trial (PSORRO)

    Gyldenløve, Mette, Sørensen, J. A., Fage, S., Meteran, H., Skov, Lone, Zachariae, Claus, Knop, Filip Krag, Nielsen, M. L. & Egeberg, Alexander, 2024, (Accepted/In press) In: Journal of the American Academy of Dermatology.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2023
  4. Published

    Cutaneous vascular calcifications in patients with chronic kidney disease and calcific uremic arteriolopathy: a cross-sectional study

    Røndbjerg, A. K., Gyldenløve, Mette, Krustrup, D., Rix, M., Vejborg, I., Lönn, Lars, Jørgensen, Niklas Rye, Pasch, A., Skov, Lone & Hansen, Ditte, 2023, In: Journal of Nephrology. 36, p. 1991–1999 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO)

    Gyldenløve, Mette, Meteran, H., Sørensen, J. A., Fage, S., Yao, Y., Lindhardsen, Jesper, Nissen, Christoffer Valdemar S, Todberg, T., Thomsen, Simon Francis, Skov, Lone, Zachariae, Claus, Iversen, L., Nielsen, M. & Egeberg, Alexander, 2023, In: The Lancet Regional Health - Europe. 30, 10 p., 100639.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Long‐term clearance of severe plaque psoriasis with oral roflumilast

    Gyldenløve, Mette, Meteran, H., Zachariae, Claus & Egeberg, Alexander, 2023, In: Journal of the European Academy of Dermatology and Venereology. 37, 3, p. e429-e430

    Research output: Contribution to journalComment/debateResearchpeer-review

  7. Published

    Oral glucose has little or no effect on appetite and satiety sensations despite a significant gastrointestinal response

    Lauritsen, J. V., Bergmann, N., Junker, A. E., Gyldenløve, Mette, Skov, Lone, Gluud, Lise Lotte, Hartmann, Bolette, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2023, In: European Journal of Endocrinology. 189, 6, p. 619-626 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. 2022
  9. Published

    Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review

    Gyldenløve, Mette, Alinaghi, F., Zachariae, Claus, Skov, Lone & Egeberg, Alexander, 2022, In: American Journal of Clinical Dermatology. 23, 5, p. 605-613

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Considerable improvement in hidradenitis suppurativa with oral roflumilast therapy

    Ring, H. C., Egeberg, Alexander, Zachariae, Claus, Thomsen, Simon Francis & Gyldenløve, Mette, 2022, In: British Journal of Dermatology. 187, 5, 2 p.

    Research output: Contribution to journalLetterResearchpeer-review

  11. Published

    Killing all the birds with one drug–is oral roflumilast a novel treatment option for psoriasis?

    Gyldenløve, Mette & Egeberg, Alexander, 2022, In: Journal of Dermatological Treatment. 33, 6, p. 2782-2783 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Rapid clearing of refractory nummular dermatitis with oral roflumilast therapy

    Gyldenløve, Mette, Zachariae, Claus, Thyssen, Jacob Pontoppidan & Egeberg, Alexander, 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 10, p. e765-e766

    Research output: Contribution to journalComment/debateResearchpeer-review

  13. Published

    Rapid improvement of idiopathic aphthous ulcers with oral roflumilast therapy

    Gyldenløve, Mette, Meteran, Howraman, Zachariae, Claus & Egeberg, Alexander, 2022, In: British Journal of Dermatology. 187, 2, p. 258-259 2 p.

    Research output: Contribution to journalLetterResearchpeer-review

ID: 308239401